Piper Sandler turns positive on CAPR ahead of FDA DMD decision
Piper Sandler turned positive on Capricor Therapeutics (CAPR), saying potential upside from an FDA approval of its Duchenne muscular dystrophy treatment outweighs downside risk.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.